The theoretical bases of Hodgkin's disease (HD) have recently been revised in the light of
new findings obtained by means of immunohistochemistry and molecular analysis. These …

Hodgkin lymphoma (HL) is composed of two distinct pathological entities, nodular
lymphocyte predominant HL and classic HL, the latter with four subtypes. In contrast with …

Abstract The Hodgkin and Reed-Sternberg (HRS) tumor cells of classical Hodgkin
lymphoma (HL), as well as the lymphocyte predominant (LP) cells of nodular lymphocyte …

Purpose: Recent studies have suggested that lymphocyte-predominant Hodgkin's disease
(LPHD) is both clinically and pathologically distinct from other forms of Hodgkin's disease …

The Hodgkin lymphoma (HL) is a B-cell lymphoma, as was proved by molecular studies with
single-cell PCR. Histologically, it is characterized by a minority of neoplastic cells, Reed …

Hodgkin's disease is considered a distinct clinical entity, but it exhibits a wide range of
histologic and cytologic features. Four histologic subtypes and numerous variant subtypes …

Hodgkin's lymphoma is a lymphoid tumour that represents about 1% of all de novo
neoplasms occurring every year worldwide. Its diagnosis is based on the identification of …

Hodgkin's lymphoma was first described in 1832. The aetiology of this lymphoma, however,
remained enigmatic for a long time. Only within the past 10 years has the B-cell nature of the …

According to the WHO classification, Hodgkin's lymphoma (HL) is subdivided into a classical
variant and a nodular lymphocyte predominant variant which are characterized by the …

Hodgkin lymphoma (HL) encompasses 2 unique clinicopathologic entities, classical
Hodgkin lymphoma (CHL)(∼ 95% of cases) and nodular lymphocyte predominant HL (∼ …